NTRK1 and melanoma: In response to MAPK pathway inhibition, some melanoma cells undergo transcriptional reprogramming towards a melanocytic lineage dedifferentiation cell state characterized by the expression of receptor tyrosine kinases such as AXL, PDGFRβ or NGFR [6, 14, 31, 34, 35].